DÖRT FARKLI DÎYALÎZERİN LENFOSİT ALT GRUPLARI ÜZERİNE AKUT ETKİLERİNİN KARŞILAŞTIRILMASI
Journal Name:
- Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi
Publication Year:
- 2001
Keywords (Original Language):
Author Name | University of Author | Faculty of Author |
---|---|---|
REFERENCES
1. Goldblum SE, Reed WP. Host defences and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980; 93: 567-613.
2. Doubbelstein H. Immune system in uremia. Nephron 1979; 17:409-414.
3. Lindner A, Farewell VT, Sherrard DJ. High incidence of neoplasia in uremic patients receiving long-term
dialysis. Nephron 1979; 27: 292-296.
4. Kurz P, Kahler H, Meuer S, Hutteroth T, Meyer zum Buschenfelde KH. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect.
Kidney int 1986; 29: 1209-1214.
5.
Uta
ş C, Akpolat T. Biyouyumluluk. Akpolat T, Utaş C (ed). Hemodiyaliz Hekimi El Kitabı. 1. Baskı. Erciyes Üniversitesi Matbaası, Kayseri, 1997; s: 105-107.
6. Chida Y, Sakumi T, Yoshiyama N. The effect of hemodialysis on lymphocyte subsets during dialysis.
Clin Nephrol 1986; 25: 159-163.
7. Grooteman MP, Nube MJ, van Limbeek J, Schoorl M, van Houte AJ. Lymphocyte subsets in dialyser eluates: a new parameter of bioincompatibility? Nephrol Dial
Transplant 1996; 11: 1073-1078.
8.
Sa
n A. Hemodiyaliz membranlarının biyokompatibilitesi. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 1995; 3: 126-130.
9. Paydaş S. Biyokompatibilite. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 1996; 2: 43-45.
10. Kaplow L, Goffinet J. Profound neutropenia during the
early phase of hemodialysis. JAMA 1968; 203: 1135 -1137.
11.
Falkenhage
n D, Bosch T, Brown GS, Schmidt B, Holtz M, Baurmeister U, Gurland H, Klinkmann H. A clinical study on different cellulosic dialysis membranes.
Nephrol Dial Transplant 1987: 2: 537-545.
12. Cheung AK. Complement activation as index of hemodialysis membrane biocompatibility: the choice of methods on assays. Nephrol Dial Transplant 1994; 9
(suppl.2): 96-103.
13. Cheung AK, Parker JP, Wilcox LA, Janatova J. Activation of comlement by hemodialysis membranes: polyacrylonitrile binds more C3Ca than cuprophan.
Kidney Int 1990; 37:1055-1059.
14.
Masak
i T, Gilson J, Leypoldt JK, Cheung AK. Effect of permeability on indices of haemodialysis membrane biocompatibility. Nephrol Dial Transplant 1999; 14: 1176-1181.
15. Wilson WEC, Kirkpatrick CH, Talmage DW.
Suppression of immunologic responsiveness in uremia. Ann Intern Med 1965; 62: 1-14.
16. Hoy WE, Cestero RV, Freeman RB. Deficiency of T and B lymphocytes in uremic subjects and partial improvement with maintenance hemodialysis. Nephron
1978; 20: 182-188.
17. Quandracci LJ, Ringden O, Krzymanski M. The effect of uremia and transplantation on lymphocyte
subpopulations. Kidney Int 1976; 10: 179-184.
18. Touraine JL, Toureine F, Revillard JP, Brochier J, Traeger J. T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. Nephron
1975; 14: 195-208.
19. Ueki Y, Nagata M, Miyake S, Taminaga Y. Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin. J Clin
Immunol 1993; 13:279-287.
20. Morra L, Ponassi GA, Gurreri G, Moccia F, Mela GS, Bessone G. T lymphocyte subsets in chronic uremic patients treated with maintenance hemodialysis.
Biomed Pharmacother 1990; 44: 53-56.
21. Hakim RM, Lowrie EG. Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyser membrane materials. Nephron 1982; 32: 32-39.
22. Zapui P, Green W, Hakim RM. Hemodiyalisis with cuprophane membrane modulates interleukin-2 receptor
expression. Kidney Int 1991; 39: 1020-1026.